Journal of Pharmacokinetics & Experimental Therapeutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • J Pharmacokinet Exp Ther 2022, Vol 6(6): 159
  • DOI: 10.4172/jpet.1000159

A Brief Review on Medication in the Statin Family that Lowers Cholesterol-Atorvastatin (Lipitor)

John Stevens*
Department of Family and Community Medicine, University of North Texas Health Science Center, United States
*Corresponding Author : John Stevens, Department of Family and Community Medicine, University of North Texas Health Science Center, United States, Email: ohn_29@hotmail.com

Received Date: Nov 22, 2022 / Accepted Date: Dec 19, 2022 / Published Date: Dec 20, 2022

Abstract

An HMG-CoA reductase inhibitor called atorvastatin is used to lower cholesterol levels and lessen the risk of cardiovascular disease, including as myocardial infarction and stroke. The objective of this paper is to provide a brief note on the pharmacokinetics of lipid-lowering medicine belonging to the statin class of drugs is Atorvastatin.

Citation: Stevens J (2022) A Brief Review on Medication in the Statin Family thatLowers Cholesterol -Atorvastatin (Lipitor). J Pharmacokinet Exp Ther 6: 159. Doi: 10.4172/jpet.1000159

Copyright: © 2022 Stevens J. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top